Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.

Market Analysis and Insights: Global Tardive Dyskinesia (TD) Treatment Drugs Market

The global Tardive Dyskinesia (TD) Treatment Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Tardive Dyskinesia (TD) Treatment Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Tardive Dyskinesia (TD) Treatment Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tardive Dyskinesia (TD) Treatment Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tardive Dyskinesia (TD) Treatment Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tardive Dyskinesia (TD) Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tardive Dyskinesia (TD) Treatment Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Tardive Dyskinesia (TD) Treatment Drugs Market Report

Report Metric	Details
Report Name	Tardive Dyskinesia (TD) Treatment Drugs Market
CAGR	5%
Segment by Type	Valbenazine Deutetrabenazine
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries, Pfizer Inc., Biogen, Novartis AG, AstraZeneca, GlaxoSmithKline plc., Bayer AG, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Tardive Dyskinesia (TD) Treatment Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tardive Dyskinesia (TD) Treatment Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tardive Dyskinesia (TD) Treatment Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Tardive Dyskinesia (TD) Treatment Drugs Market report?

Ans: The main players in the Tardive Dyskinesia (TD) Treatment Drugs Market are Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries, Pfizer Inc., Biogen, Novartis AG, AstraZeneca, GlaxoSmithKline plc., Bayer AG, Sanofi

What are the Application segmentation covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report?

Ans: The Applications covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report?

Ans: The Types covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report are Valbenazine, Deutetrabenazine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Valbenazine

1.2.3 Deutetrabenazine

1.3 Market by Application

1.3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Perspective (2019-2030)

2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Growth Trends by Region

2.2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Region (2019-2024)

2.2.3 Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Region (2025-2030)

2.3 Tardive Dyskinesia (TD) Treatment Drugs Market Dynamics

2.3.1 Tardive Dyskinesia (TD) Treatment Drugs Industry Trends

2.3.2 Tardive Dyskinesia (TD) Treatment Drugs Market Drivers

2.3.3 Tardive Dyskinesia (TD) Treatment Drugs Market Challenges

2.3.4 Tardive Dyskinesia (TD) Treatment Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Tardive Dyskinesia (TD) Treatment Drugs by Players

3.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2019-2024)

3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio

3.4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2023

3.5 Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs Head office and Area Served

3.6 Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Product and Application

3.7 Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Type

4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Type (2019-2024)

4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2025-2030)

5 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Application

5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Application (2019-2024)

5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2019-2030)

6.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type

6.2.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)

6.2.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030)

6.2.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

6.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application

6.3.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)

6.3.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030)

6.3.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

6.4 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country

6.4.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024)

6.4.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size (2019-2030)

7.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type

7.2.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)

7.2.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030)

7.2.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application

7.3.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)

7.3.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030)

7.3.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

7.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country

7.4.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024)

7.4.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Tardive Dyskinesia (TD) Treatment Drugs Market Size (2019-2030)

8.2 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type

8.2.1 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)

8.2.2 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030)

8.2.3 China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

8.3 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application

8.3.1 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)

8.3.2 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030)

8.3.3 China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size (2019-2030)

9.2 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type

9.2.1 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)

9.2.2 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030)

9.2.3 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

9.3 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application

9.3.1 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)

9.3.2 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030)

9.3.3 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

9.4 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region

9.4.1 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024)

9.4.3 Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Neurocrine Biosciences, Inc.

11.1.1 Neurocrine Biosciences, Inc. Company Details

11.1.2 Neurocrine Biosciences, Inc. Business Overview

11.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.1.4 Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.1.5 Neurocrine Biosciences, Inc. Recent Developments

11.2 Teva Pharmaceutical Industries

11.2.1 Teva Pharmaceutical Industries Company Details

11.2.2 Teva Pharmaceutical Industries Business Overview

11.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.2.4 Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.2.5 Teva Pharmaceutical Industries Recent Developments

11.3 Pfizer Inc.

11.3.1 Pfizer Inc. Company Details

11.3.2 Pfizer Inc. Business Overview

11.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.3.4 Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.3.5 Pfizer Inc. Recent Developments

11.4 Biogen

11.4.1 Biogen Company Details

11.4.2 Biogen Business Overview

11.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.4.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.4.5 Biogen Recent Developments

11.5 Novartis AG

11.5.1 Novartis AG Company Details

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.5.4 Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.5.5 Novartis AG Recent Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.6.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.6.5 AstraZeneca Recent Developments

11.7 GlaxoSmithKline plc.

11.7.1 GlaxoSmithKline plc. Company Details

11.7.2 GlaxoSmithKline plc. Business Overview

11.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.7.4 GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.7.5 GlaxoSmithKline plc. Recent Developments

11.8 Bayer AG

11.8.1 Bayer AG Company Details

11.8.2 Bayer AG Business Overview

11.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.8.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.8.5 Bayer AG Recent Developments

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.9.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

11.9.5 Sanofi Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Neurocrine Biosciences Inc

Teva Pharmaceutical Industries

List of Tables

Table 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Valbenazine

Table 3. Key Players of Deutetrabenazine

Table 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2019-2024)

Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2025-2030)

Table 10. Tardive Dyskinesia (TD) Treatment Drugs Market Trends

Table 11. Tardive Dyskinesia (TD) Treatment Drugs Market Drivers

Table 12. Tardive Dyskinesia (TD) Treatment Drugs Market Challenges

Table 13. Tardive Dyskinesia (TD) Treatment Drugs Market Restraints

Table 14. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Players (2019-2024)

Table 16. Global Top Tardive Dyskinesia (TD) Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2023)

Table 17. Global Tardive Dyskinesia (TD) Treatment Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Headquarters and Area Served

Table 20. Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Product and Application

Table 21. Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Application (2019-2024)

Table 29. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Application (2025-2030)

Table 31. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Tardive Dyskinesia (TD) Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Tardive Dyskinesia (TD) Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Tardive Dyskinesia (TD) Treatment Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 63. Neurocrine Biosciences, Inc. Company Details

Table 64. Neurocrine Biosciences, Inc. Business Overview

Table 65. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product

Table 66. Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 67. Neurocrine Biosciences, Inc. Recent Developments

Table 68. Teva Pharmaceutical Industries Company Details

Table 69. Teva Pharmaceutical Industries Business Overview

Table 70. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product

Table 71. Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 72. Teva Pharmaceutical Industries Recent Developments

Table 73. Pfizer Inc. Company Details

Table 74. Pfizer Inc. Business Overview

Table 75. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product

Table 76. Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 77. Pfizer Inc. Recent Developments

Table 78. Biogen Company Details

Table 79. Biogen Business Overview

Table 80. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product

Table 81. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 82. Biogen Recent Developments

Table 83. Novartis AG Company Details

Table 84. Novartis AG Business Overview

Table 85. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product

Table 86. Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 87. Novartis AG Recent Developments

Table 88. AstraZeneca Company Details

Table 89. AstraZeneca Business Overview

Table 90. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product

Table 91. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 92. AstraZeneca Recent Developments

Table 93. GlaxoSmithKline plc. Company Details

Table 94. GlaxoSmithKline plc. Business Overview

Table 95. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product

Table 96. GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 97. GlaxoSmithKline plc. Recent Developments

Table 98. Bayer AG Company Details

Table 99. Bayer AG Business Overview

Table 100. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product

Table 101. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 102. Bayer AG Recent Developments

Table 103. Sanofi Company Details

Table 104. Sanofi Business Overview

Table 105. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product

Table 106. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024) & (US$ Million)

Table 107. Sanofi Recent Developments

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type: 2023 VS 2030

Figure 3. Valbenazine Features

Figure 4. Deutetrabenazine Features

Figure 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered

Figure 11. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region: 2023 VS 2030

Figure 14. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players in 2023

Figure 15. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2023

Figure 17. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

Figure 19. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

Figure 20. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2019-2030)

Figure 21. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

Figure 25. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

Figure 26. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2019-2030)

Figure 27. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

Figure 35. China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

Figure 36. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

Figure 38. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

Figure 39. Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2019-2030)

Figure 40. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2019-2030)

Figure 50. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Neurocrine Biosciences, Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 58. Pfizer Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 59. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 60. Novartis AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 61. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 62. GlaxoSmithKline plc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 63. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 64. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tardive Dyskinesia Treatment Market Research Report 2024

Tardive Dystonia Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tardive Dystonia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030

Tourette Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tourette Syndrome Drug Market Research Report 2024

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030

Global Addictions Therapeutics Market Insights Forecast to 2030

Valbenazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Disruptive Behavior Disorder DBD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dystonia Drugs Market Research Report 2025

Global Learning Disability Treatment Market Insights Forecast to 2030

Deutetrabenazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stuttering Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antipsychotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroleptics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tiapride Market Insights Forecast to 2030

Global Frontotemporal Dementia Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions